ES2134634T3 - Composiciones farmaceuticas y dispositivos para su administracion. - Google Patents

Composiciones farmaceuticas y dispositivos para su administracion.

Info

Publication number
ES2134634T3
ES2134634T3 ES96929413T ES96929413T ES2134634T3 ES 2134634 T3 ES2134634 T3 ES 2134634T3 ES 96929413 T ES96929413 T ES 96929413T ES 96929413 T ES96929413 T ES 96929413T ES 2134634 T3 ES2134634 T3 ES 2134634T3
Authority
ES
Spain
Prior art keywords
administration
devices
pharmaceutical compositions
hfc
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96929413T
Other languages
English (en)
Inventor
Michael Goodman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioglan Laboratories Ltd
Original Assignee
Bioglan Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10780152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2134634(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioglan Laboratories Ltd filed Critical Bioglan Laboratories Ltd
Application granted granted Critical
Publication of ES2134634T3 publication Critical patent/ES2134634T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B65D83/38—Details of the container body
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B65D83/44—Valves specially adapted for the discharge of contents; Regulating devices
    • B65D83/52—Metering valves; Metering devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

DISPOSITIVO PARA LA ADMINISTRACION DE DOSIS FARMACEUTICAS QUE CONSTA DE UN RECIPIENTE LLENO DE UNA COMPOSICION FARMACEUTICA QUE CONTIENE TRINITRATO DE GLICERILO Y 1,1,1,2 - TETRAFLUOROETANO (HFC - 134A) O 1,1,1,2,3,3,3 - HEPTAFLUOROPROPANO (HFC - 227) COMO PROPELENTE, Y UN SISTEMA VALVULAR DISPUESTO PARA LA ADMINISTRACION DE DOSIS PARA NEBULIZADOR DE DICHA COMPOSICION FARMACEUTICA AL EXTERIOR DEL ENVASE, DONDE SE FORMA AL MENOS UNA PARTE DEL DISPOSITIVO A PARTIR DE UN POLIESTER. SE DESCRIBEN TAMBIEN LAS COMPOSICIONES A UTILIZAR EN ESTOS DISPOSITIVOS.
ES96929413T 1995-09-04 1996-09-04 Composiciones farmaceuticas y dispositivos para su administracion. Expired - Lifetime ES2134634T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9517998.2A GB9517998D0 (en) 1995-09-04 1995-09-04 Compositions and device for their administration

Publications (1)

Publication Number Publication Date
ES2134634T3 true ES2134634T3 (es) 1999-10-01

Family

ID=10780152

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96929413T Expired - Lifetime ES2134634T3 (es) 1995-09-04 1996-09-04 Composiciones farmaceuticas y dispositivos para su administracion.

Country Status (16)

Country Link
EP (1) EP0848607B1 (es)
JP (1) JP2001507330A (es)
KR (1) KR100281626B1 (es)
AT (1) ATE180665T1 (es)
AU (1) AU699885B2 (es)
CA (1) CA2213774C (es)
DE (1) DE69602759T2 (es)
DK (1) DK0848607T3 (es)
ES (1) ES2134634T3 (es)
GB (1) GB9517998D0 (es)
GR (1) GR3030405T3 (es)
NO (1) NO980858L (es)
NZ (1) NZ316568A (es)
TR (1) TR199700957T1 (es)
WO (1) WO1997009034A1 (es)
ZA (1) ZA967464B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU695969B2 (en) * 1993-04-30 1998-08-27 Minnesota Mining And Manufacturing Company Seal configuration for aerosol canister
JP2001505171A (ja) * 1996-12-04 2001-04-17 バイオグラン アイルランド（アール アンド ディ）リミテッド 製薬組成物及びその投与のための装置
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
GB2326334A (en) † 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
GB9805938D0 (en) 1998-03-19 1998-05-13 Glaxo Group Ltd Valve for aerosol container
FR2776741B1 (fr) * 1998-03-30 2000-05-19 Valois Sa Valve doseuse amelioree
FR2791032B1 (fr) * 1999-03-16 2001-06-01 Valois Sa Procede d'assemblage et de remplissage d'un dispositif de distribution de produit fluide
TW523409B (en) * 2000-09-15 2003-03-11 Baxter Int Container for inhalation anesthetic
DE20212802U1 (de) * 2002-08-15 2002-11-07 Kersten, Olaf, Dr.-Ing., 47802 Krefeld Abgabeventil mit Beutel
US7169805B2 (en) * 2003-05-28 2007-01-30 Nicox S.A. Captopril derivatives
WO2007123955A2 (en) * 2006-04-19 2007-11-01 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
KR100858320B1 (ko) 2007-02-14 2008-09-17 박영주 유체용기
US9278048B2 (en) 2009-05-06 2016-03-08 Baxter International, Inc. Pharmaceutical product and method of use
US9789071B2 (en) 2012-06-27 2017-10-17 G2B Pharma, Inc. Intranasal formulation of epinephrine for the treatment of anaphylaxis
US10626178B2 (en) 2013-08-21 2020-04-21 Raz Yirmiya Treatment of mood and stress related disorders
WO2015025323A1 (en) 2013-08-21 2015-02-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Treatment of mood and stress related disorders
IL259810A (en) 2018-06-04 2018-07-31 Yeda Res & Dev Mitogen-activated protein kinase kinase 7 inhibitors
IL260690A (en) 2018-07-19 2018-12-31 Yeda Res & Dev Sphingosine derivatives and their use against pulmonary bacterial infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3246081A1 (de) * 1982-12-13 1984-06-14 G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt Nitroglycerin-spray
JP2644282B2 (ja) * 1988-05-20 1997-08-25 サンスター株式会社 ヨード系殺菌剤組成物
DE4018919C2 (de) * 1990-06-13 1994-08-25 Sanol Arznei Schwarz Gmbh Nitroglycerin-Spray
GB9017673D0 (en) * 1990-08-11 1990-09-26 Fisons Plc Container
DE4038203A1 (de) * 1990-11-30 1992-06-04 Kali Chemie Pharma Gmbh Pharmazeutische spray-zubereitungen mit coronaraktiven wirkstoffen

Also Published As

Publication number Publication date
EP0848607A1 (en) 1998-06-24
NO980858L (no) 1998-05-04
NZ316568A (en) 2000-02-28
CA2213774A1 (en) 1997-03-13
KR19980702874A (ko) 1998-08-05
DK0848607T3 (da) 1999-06-23
KR100281626B1 (ko) 2001-02-15
JP2001507330A (ja) 2001-06-05
NO980858D0 (no) 1998-02-27
CA2213774C (en) 2005-08-30
DE69602759D1 (de) 1999-07-08
TR199700957T1 (xx) 1998-02-21
EP0848607B1 (en) 1999-06-02
GR3030405T3 (en) 1999-09-30
AU6882796A (en) 1997-03-27
AU699885B2 (en) 1998-12-17
GB9517998D0 (en) 1995-11-08
WO1997009034A1 (en) 1997-03-13
DE69602759T2 (de) 1999-10-07
ZA967464B (en) 1997-05-27
ATE180665T1 (de) 1999-06-15

Similar Documents

Publication Publication Date Title
ES2180592T3 (es) Formulaciones en aerosol libres de clorofluorocarbonos.
ES2156840T1 (es) Medicamento que contiene polisulfato de pentosano e implante para tratar la fibrosis.
AR012927A1 (es) Una composicion farmaceutica, una forma de dosificacion farmaceutica, el uso de dicha composicion para la fabricacion de un medicamento y una forma depresentacion farmaceutica adecuada para la venta comercial
AR009231A1 (es) Formulaciones en aerosol de formoterol.
ES2064160T3 (es) Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
DK0656207T3 (da) Aerosolformuleringer uden chlorfluorcarbonforbindelser
DE69205177D1 (de) Pharmazeutische Aerosolformulierung.
AR002754A1 (es) Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento
DE60114571D1 (de) Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
ES2094539T3 (es) Preparacion farmaceutica y procedimiento para su preparacion.
DE69602759D1 (de) Pharmazeutische zusammensetzungen und vorrichtungen zu deren verabreichung
AR008886A1 (es) Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea
ES2099649T3 (es) Nueva composicion farmaceutica destinada para la fabricacion de un polvo estable que contiene, a titulo de ingrediente activo, una asociacion de acido acetilsalicilico y de metoclopramida.
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
ES2059130T3 (es) Composiciones farmaceuticas que contienen ipriflavona, procedimiento para su preparacion y uso terapeutico relacionado.
CO5550418A2 (es) Formulaciones antihistaminicas para formas de dosificacion de capsula blanda
DE60318182D1 (de) Aerosol-formulierungen mit estern von 3,17-dihydroxyöstratrien-derivaten zur pulmonalen abgabe
CO4480718A1 (es) Dosificacion de formas solidas que contienen una baja dosis de un farmaco

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 848607

Country of ref document: ES